BioNTech CEO Ugur Sahin told Reuters that doses of the coronavirus vaccine could be available for some in the US and Europe by next month, pending regulatory approval.
BioNTech CEO Ugur Sahin told Reuters that doses of the coronavirus vaccine could be available for some in the US and Europe by next month, pending regulatory approval.